SEOUL, South Korea, Dec. 19, 2023 /PRNewswire/ -- Standigm
SEOUL, South Korea, Sept. 12, 2023 /PRNewswire/ -- On September 5th, 2023 Standigm, a company using...
Companies will identify novel therapeutic targets using Standigm's explainable AI and Nashville Bio...
Former LG life Sciences exec and long-time Standigm advisor brings extensive experience in pharmace...
Research achievements enabled by a combination of advanced AI platforms, research capabilities, an...
SEOUL, South Korea, Jan. 5, 2023 /PRNewswire/ -- Standigm
Lab uniquely enables collaboration between chemical and AI researchers SEOUL, South Korea, Nov. 16,...
Standigm will present AI-driven drug discovery technology at the conference CAMBRIDGE, England, Oct...
Veteran biotech and pharmaceutical executive will help company increase its growth and internationa...
Winners to Be Celebrated During Event in London on 15 October SEOUL, South Korea, Aug. 16, 2022 /PR...
- Merck's retrosynthesis AI software 'SYNTHIA™ retrosynthesis software' accelerates Standigm's synt...
- Merck's retrosynthesis AI software SYNTHIA™ accelerates Standigm's synthesis capability SEOUL...
SEOUL, South Korea, Nov. 30, 2021 /PRNewswire/ -- Standigm Inc. ("Standigm"), the leading workflow ...
SEOUL, South Korea, Nov. 8, 2021 /PRNewswire/ -- Standigm Inc. ("Standigm"), the leading workflow a...
SEOUL, South Korea, Nov. 3, 2021 /PRNewswire/ -- Standigm Inc. ("Standigm"), the leading workflow a...